LIBERCHLO Trademark

Trademark Overview


On Thursday, October 18, 2018, a trademark application was filed for LIBERCHLO with the United States Patent and Trademark Office. The USPTO has given the LIBERCHLO trademark a serial number of 88160471. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Tuesday, June 8, 2021. This trademark is owned by Pfizer Inc. The LIBERCHLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
liberchlo

General Information


Serial Number88160471
Word MarkLIBERCHLO
Filing DateThursday, October 18, 2018
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateTuesday, June 8, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateTuesday, June 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, June 8, 2021ABANDONMENT NOTICE E-MAILED - AFTER PUBLICATION
Tuesday, June 8, 2021ABANDONMENT - AFTER PUBLICATION
Monday, June 7, 2021TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, March 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 26, 2021EXTENSION 4 GRANTED
Friday, March 26, 2021EXTENSION 4 FILED
Friday, March 26, 2021TEAS EXTENSION RECEIVED
Friday, September 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 16, 2020EXTENSION 3 GRANTED
Wednesday, September 16, 2020EXTENSION 3 FILED
Wednesday, September 16, 2020TEAS EXTENSION RECEIVED
Wednesday, March 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 23, 2020EXTENSION 2 GRANTED
Monday, March 23, 2020EXTENSION 2 FILED
Monday, March 23, 2020TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 6, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 4, 2019EXTENSION 1 GRANTED
Monday, November 4, 2019EXTENSION 1 FILED
Monday, November 4, 2019TEAS EXTENSION RECEIVED
Monday, November 4, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Wednesday, October 23, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 7, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 12, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 28, 2019ASSIGNED TO EXAMINER
Wednesday, October 31, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 22, 2018NEW APPLICATION ENTERED IN TRAM